Xiamen Amoytop Biotech Co., Ltd. (688278.SS)
CNY 71.53
(1.26%)
CNY 71.53
(1.26%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.76 Million CNY | -32.42% |
| 2022 | 5.56 Million CNY | -40.64% |
| 2021 | 9.37 Million CNY | 3.17% |
| 2020 | 9.08 Million CNY | 60980079886336100.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 3 Million CNY | 0.0% |
| 2024 Q2 | 5.87 Million CNY | 0.0% |
| 2024 Q3 | 5.45 Million CNY | 0.0% |
| 2023 Q4 | 3.76 Million CNY | -13.75% |
| 2023 Q3 | 4.36 Million CNY | -19.73% |
| 2023 Q1 | 10.05 Million CNY | 80.73% |
| 2023 FY | 3.76 Million CNY | -32.42% |
| 2023 Q2 | 5.43 Million CNY | -45.99% |
| 2022 Q2 | 7.44 Million CNY | -8.8% |
| 2022 Q1 | 8.16 Million CNY | -12.88% |
| 2022 Q3 | 6.66 Million CNY | -10.46% |
| 2022 FY | 5.56 Million CNY | -40.64% |
| 2022 Q4 | 5.56 Million CNY | -16.56% |
| 2021 Q1 | 11.89 Million CNY | 30.85% |
| 2021 Q2 | 16.15 Million CNY | 35.86% |
| 2021 Q4 | 9.37 Million CNY | -40.82% |
| 2021 Q3 | 15.84 Million CNY | -1.94% |
| 2021 FY | 9.37 Million CNY | 3.17% |
| 2020 Q4 | 9.08 Million CNY | 60980079886336100.0% |
| 2020 Q1 | 2.00 CNY | 13421772900.0% |
| 2020 FY | 9.08 Million CNY | 60980079886336100.0% |
| 2020 Q3 | - CNY | -200.0% |
| 2020 Q2 | - CNY | -100.0% |
| 2019 Q3 | 1.00 CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q4 | - CNY | -100.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |